Liver Disease as a Cause of Urine Colour Change

The bilirubin pathway and why urine darkens

Bilirubin is the yellow-orange breakdown product of haemoglobin from old red blood cells. The liver takes up unconjugated (water-insoluble, fat-soluble) bilirubin from blood, conjugates it with glucuronic acid to make it water-soluble, and then excretes the conjugated form in bile, where it travels through the bile ducts to the small intestine. In the gut, bacteria convert it to urobilinogen and then stercobilin, which gives faeces their brown colour. A small amount of urobilinogen is reabsorbed and excreted in urine, where it gives normal urine its faint yellow tint.

When the liver is damaged or the bile ducts are blocked, conjugated (water-soluble) bilirubin spills back into the bloodstream. Because conjugated bilirubin is water-soluble, it is freely filtered by the kidneys and appears in urine, giving it a tea, brown, or coffee colour. At the same time, less bilirubin reaches the gut, so faeces become pale or clay-coloured. The combination of dark urine plus pale stools plus yellow skin and eyes (jaundice) is the classic obstructive or hepatocellular jaundice triad. The Merck Manual professional jaundice reference covers the mechanism in clinical detail.

The colour intensity correlates roughly with the bilirubin level. Mild jaundice (bilirubin around 50 mmol/L) may produce only a slight darkening of urine and yellowing of the sclera (whites of the eyes). Marked jaundice (bilirubin above 200 mmol/L) typically produces clearly dark urine and obvious skin yellowing.

Acute viral hepatitis (A, B, C, E)

Acute viral hepatitis is one of the leading causes of dark urine plus jaundice, particularly in younger adults. Common causes are hepatitis A (faecal-oral spread, usually from contaminated food or water, often acquired during travel), hepatitis B (blood and body fluid spread, including sexual transmission and mother-to-baby), hepatitis C (predominantly blood-borne, including from injecting drug use historically), and hepatitis E (faecal-oral, increasingly recognised in higher-income countries, often from undercooked pork). The NHS hepatitis overview covers all four.

The classic acute hepatitis presentation is a flu-like prodrome (fatigue, mild fever, nausea, loss of appetite) for several days, followed by darkening of urine, paling of stools, and the appearance of yellow eyes and skin. Right-upper-quadrant discomfort is common from the inflamed liver. The CDC hepatitis reference covers the typical timecourse for each virus.

Acute hepatitis A is usually self-limiting in healthy adults. Acute hepatitis B is mostly self-limiting in adults but causes chronic infection in 5-10 % of adult cases. Acute hepatitis C is usually mild but progresses to chronic infection in about 75 % of cases (and is now curable with direct-acting antivirals). Hepatitis E in pregnancy carries a higher fatality risk than in the general population.

Biliary obstruction (gallstones, tumours)

Biliary obstruction is the second leading cause of jaundice. Gallstones in the common bile duct (choledocholithiasis) can block bile drainage from the liver to the gut. The NHS gallstones guidance describes the typical presentation as severe right-upper-quadrant pain, sometimes radiating to the right shoulder, often after a fatty meal, with jaundice if the stone has reached the common bile duct.

Pancreatic head tumours can compress the common bile duct as it passes through the pancreas, producing painless jaundice. This presentation has a poor prognosis and the NICE NG12 suspected cancer guideline recommends urgent referral for any unexplained jaundice in adults over 40 (within 2 weeks).

Cholangitis is bacterial infection of the obstructed biliary tree. Charcot's triad (right-upper-quadrant pain, fever, jaundice) is classic, and the addition of hypotension and confusion (Reynolds' pentad) signals a severe presentation. Cholangitis is a surgical emergency requiring IV antibiotics and urgent biliary drainage by ERCP (endoscopic retrograde cholangiopancreatography) or percutaneous drainage.

Alcoholic and non-alcoholic liver disease

Alcohol-related liver disease is a leading cause of chronic liver damage in the UK. The spectrum runs from simple fatty liver (steatosis, reversible with abstinence) to alcoholic steatohepatitis to cirrhosis. The NHS alcohol-related liver disease guidance covers the spectrum.

Severe alcoholic hepatitis can present with rapid-onset jaundice, dark urine, fever, abdominal pain, and confusion. The Maddrey discriminant function and Glasgow alcoholic hepatitis score help risk-stratify severity. Severe cases have substantial short-term mortality and may benefit from corticosteroid treatment. The British Liver Trust patient resources cover the lived experience and the help available.

Non-alcoholic fatty liver disease (NAFLD, increasingly called metabolic-dysfunction-associated steatotic liver disease, MASLD) is now the leading liver disease in many populations, driven by obesity, type 2 diabetes, and metabolic syndrome. Most NAFLD is asymptomatic in early stages. Progression to MASH (metabolic-dysfunction-associated steatohepatitis) and cirrhosis can produce jaundice and dark urine in advanced disease. The NICE NG49 NAFLD guideline covers screening and management.

Drug-induced liver injury

A wide range of medications can cause liver injury. The NHS paracetamol overdose guidance is clear that even small overdoses can cause liver damage, and that symptoms develop over days. Anyone who has taken more than the recommended dose should attend A&E urgently regardless of how they feel, because early treatment with N-acetylcysteine prevents liver failure.

Other drugs with notable liver toxicity profiles include some antibiotics (co-amoxiclav, flucloxacillin, isoniazid), antiepileptics, statins, and many herbal preparations. The LiverTox database on NCBI Bookshelf catalogues drug-induced liver injury patterns and is the standard professional reference.

Frequently asked questions